NCT02055989View on ClinicalTrials.gov

A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2011

Conditions
Locally Advanced Larynx, Hypopharyngeal Squamous Cell CancersLocally Advanced Thyroid Cancers
Interventions
RADIATION

Dose-escalated radiotherapy level 1

RADIATION

Sequential dose-escalated radiotherapy level 2

Trial Locations (1)

SW3 6JJ

Royal Marsden Hospital, London

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT02055989 - A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | Biotech Hunter | Biotech Hunter